Composition
- Active ingredients
- ELAGOLIX SODIUM EQ 150MG BASE
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- ELAGOLIX SODIUM EQ 150MG BASE · TabletThis page
- ELAGOLIX SODIUM EQ 200MG BASE · TabletNDA210450-002 · Prescription
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA210450.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Orilissa
- Active substance
- elagolix sodium
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Abbvie
- Status
- Prescription
- FDA approval
- 23 Jul 2018
- Application
- NDA210450-001